Safety of High-Dose Atorvastatin Therapy

This publication has 54 references indexed in Scilit:

• Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
  New England Journal of Medicine, 2005
• Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study
  The American Journal of Cardiology, 2004
• Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
  New England Journal of Medicine, 2004
• Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
  JAMA, 2004
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)
  Published by Elsevier ,2003
• ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol
  Circulation, 2002
• Withdrawal of cerivastatin from the world market
  Trials, 2001
• Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled Trial
  JAMA, 2001
• Drug Treatment of Lipid Disorders
  New England Journal of Medicine, 1999
• The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day
  The American Journal of Cardiology, 1997